Treatment of hyperthyroidism with radioiodine targeted activity: A comparison between two dosimetric methods.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Physica medica (Testo stampato)

• Publication date

  2016-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ejmp.2016.05.059PMID 27245300
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A new method to evaluate the residual activity in patients undergoing (131)I thyroid therapy.

  2015cited by this paper
• A simple and accurate dosimetry protocol to estimate activity for hyperthyroidism treatment.

  2015cited by this paper
• Is Malignant Nodule Topography an Additional Risk Factor for Metastatic Disease in Low-Risk Differentiated Thyroid Cancer?

  2014cited by this paper
• Radioiodine therapy of hyperfunctioning thyroid nodules: usefulness of an implemented dose calculation algorithm allowing reduction of radioiodine amount.

  2013cited by this paper
• Accuracy and optimal timing of activity measurements in estimating the absorbed dose of radioiodine in the treatment of Graves’ disease

  2011influential reference
• An analytical model for improving absorbed dose calculation accuracy in non spherical autonomous functioning thyroid nodule.

  2011cited by this paper
• EANM procedure guidelines for therapy of benign thyroid disease

  2010cited by this paper
• Clinical outcomes after estimated versus calculated activity of radioiodine for the treatment of hyperthyroidism: systematic review and meta-analysis.

  2009cited by this paper
• Radioiodine treatment of hyperthyroidism: fixed or calculated doses; intelligent design or science?

  2007cited by this paper
• Functional Autonomies of Thyroid and Efficacy of Radioiodine Therapy

  2007cited by this paper
• Radioiodine treatment for benign thyroid diseases

  2007cited by this paper
• Verification of the agreement of two dosimetric methods with radioiodine therapy in hyperthyroid patients.

  2006cited by this paper
• Optimized radioiodine therapy for Graves' disease: Two MIRD-based models for the computation of patient-specific therapeutic 131I activity

  2006cited by this paper
• Effectiveness of radioiodine (131-I) as definitive therapy in patients with autoimmune and non-autoimmune hyperthyroidism

  2006cited by this paper
• A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves' patients.

  2004cited by this paper
• Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text

  2001cited by this paper
• Radioiodine therapy of Graves' hyperthyroidism: standard vs. calculated 131 iodine activity * . Results from a prospective, randomized, multicentre study

  1995cited by this paper
• Optimized dose planning of radioiodine therapy of benign thyroidal diseases.

  1993cited by this paper
• Werner and Ingbar's the Thyroid: A Fundamental and Clinical Text

  1991cited by this paper

• Clinical Dosimetry Models and Pathway to Integration in Routine Nuclear Medicine Practice.

  2026cites this paper
• Noduli tiroidei iperfunzionanti: quale approccio terapeutico?

  2025cites this paper
• Cure Rate of Dosimetry-based 131I Therapy in Hyperthyroidism Management

  2025cites this paper
• Theranostics of Thyroid Cancer.

  2024cites this paper
• Future trends for patient-specific dosimetry methodology in molecular radiotherapy.

  2023cites this paper
• The EANM guideline on radioiodine therapy of benign thyroid disease

  2023cites this paper
• Fundamentals of internal radiation dosimetry

  2022cites this paper
• A retrospective study with long term follow-up of Graves' disease patients treated with low activities of 131 Iodine.

  2022cites this paper
• A Systematic Review and Meta-Analysis of the Relationship Between the Radiation Absorbed Dose to the Thyroid and Response in Patients Treated with Radioiodine for Graves' Disease

  2021cites this paper
• Predictive factors of a worse response to radioactive Iodine-I131 treatment in hyperthyroidism: outcome analysis in 424 patients. A single centre experience

  2021cites this paper
• Theoretical aspects on the use of single-time-point dosimetry for radionuclide therapy

  2021cites this paper
• Full Monte Carlo internal dosimetry in nuclear medicine by means of GAMOS

  2020cites this paper
• Trattamento della tireotossicosi pre e subclinica nell’anziano: il posto della terapia radiometabolica

  2019cites this paper
• Theranosticsin nuclear medicine and oncology

  2019cites this paper
• Comment on: "Technical note: Single time point dose estimate for exponential clearance" [Med. Phys. 45(5), 2318-2324 (2018)].

  2019cites this paper
• Radioiodine Therapy of Benign Thyroid Diseases

  2019cites this paper
• Improving individualised dosimetry in radioiodine therapy for hyperthyroidism using population biokinetic modelling.

  2019cites this paper
• Dosimetry in the Radioiodine Treatment of Hyperthyroidism

  2018cites this paper
• Challenges and current views on dosing of radioactive iodine in the treatment of benign thyroid disease

  2017cites this paper